Depression is the second most common illness seen among veterans — one in eight to 10 veterans visiting a primary care physician has major depression disorder (MDD) that requires treatment. (1,2) In fact, depression plagues veterans so much that the US Department of Veterans Affairs has reported that approximately 20…
Transcranial magnetic stimulation (TMS) is a noninvasive treatment option for mental health disorders, such as depression. Although TMS is only FDA-approved for the treatment of treatment-resistant depression (2008) and OCD (2018), many doctors including myself support the off-label use of TMS to treat other mental health and behavioral conditions. (1,…
May 15, 2019
One of the most common questions we are asked here at Madison Avenue TMS & Psychiatry is, “How long until I see results with TMS?” The shortest answer is: The time it takes to notice results with TMS depends on each patient. Are there reasons why some people notice a…
February 22, 2019
Major depressive disorder affects more than 16 million adults in the United States. (1) Standard therapies for major depression include antidepressant medications and talk therapy. However, many patients don’t find relief from depressive symptoms with traditional treatments — this is referred to as treatment resistant depression (TRD). The acknowledgment that…
The brain functions through the activation of specific areas and the networks interconnecting them. When a brain area is active (or “on”) it uses more oxygen than other areas and therefore requires more blood flow to that part of the brain. Functional MRI, or fMRI, is a technology that visualizes…
October 26, 2018
Transcranial magnetic stimulation (also known as TMS) is an FDA-approved treatment for major depressive disorder. It has been studied in a variety of different populations, but has been shown to be particularly effective in treating those who are suffering from treatment-resistant depression. At Madison Avenue TMS & Psychiatry, we work…
October 25, 2018
Transcranial magnetic stimulation (TMS) treatment for depression was approved by the FDA in 2008, after the first landmark study by J.P. O’Reardon and his colleagues (read our post about it here) (1). Researchers continued to work to determine how TMS could be optimally used to help more people with depression.…